Ebola Outbreak in DR Congo Becomes Deadliest in Country’s History
Ebola outbreak in the Democratic Republic of Congo becomes the country’s deadliest, with 2,325 deaths and nearly 5,000 confirmed cases reported.... Read more.
UAE Becomes First Country to Approve New Oral Vitiligo Drug
UAE becomes the first country to approve RINVOQ for non-segmental vitiligo in adults and adolescents aged 12 and above, offering a new oral treatment option.... Read more.
UAE Energy Operator Expands Workplace Mental Health Support
IntrospeXion partners with a major UAE energy operator to deliver a workplace mental health programme focused on psychological safety, resilience and employee wellbeing.... Read more.
Abu Dhabi Doctors Perform Life-Saving Bone Marrow Transplant for Toddler
Abu Dhabi doctors successfully treat a 13-month-old with rare Omenn Syndrome through a father-donated stem cell transplant, restoring his immune function.... Read more.
Global Phase 1b Trial Advances New RSV Preventive Antibody
SK bioscience submits a global Phase 1b CTA for RSM01, an RSV preventive antibody candidate, targeting infants aged 2 weeks to 8 months.... Read more.
WHO and Lions Clubs Partner to Expand Mental Health Services in Jordan and Nepal
WHO and Lions Clubs International Foundation partner to expand mental health services, psychosocial support and awareness initiatives in Jordan and Nepal through... Read more.
More Than 10,000 Attacks on Healthcare Recorded Since 2018
WHO reports more than 10,400 attacks on healthcare since 2018, causing thousands of deaths and injuries while disrupting essential medical services worldwide.... Read more.
Global Health Agencies Strengthen One Health Collaboration to 2029
FAO, UNEP, WHO and WOAH extend the One Health Joint Plan of Action to 2029, strengthening global collaboration to address emerging health risks across people, animals... Read more.
Emergency Authorization Expands Treatment Options for New World Screwworm in Dogs
FDA grants emergency authorization for Simparica Trio to treat New World screwworm infestations in dogs and puppies, expanding veterinary treatment options.... Read more.
$80.5 Million Public Offering to Fund Development of Investigational Cancer Treatment
An $80.5 million public offering will support clinical trials, manufacturing and development of an investigational WEE1 inhibitor for ovarian cancer.
Zoetis Receives... Read more.
